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vWF secretionWeibel–Palade bodies (WPBs) are secretory organelles of endothelial cells that store the thrombogenic
glycoprotein vonWillebrand factor (vWF). Endothelial activation, e.g. by histamine and thrombin, triggers the
Ca2+-dependent exocytosis of WPB that releases vWF into the vasculature and thereby initiates platelet
capture and thrombus formation. Towards understanding the molecular mechanisms underlying this
regulated WPB exocytosis, we here identify components of the soluble N-ethylmaleimide-sensitive factor
attachment protein receptor (SNARE) machinery associated with WPB. We show that vesicle-associated
membrane protein (VAMP) 3 and VAMP8 are present onWPB and that VAMP3, but not VAMP8 forms a stable
complex with syntaxin 4 and SNAP23, two plasma membrane-associated SNAREs in endothelial cells. By
introducing mutant SNARE proteins into permeabilized endothelial cells we also show that soluble VAMP3
but not VAMP8 mutants comprising the cytoplasmic domain interfere with efﬁcient vWF secretion. This
indicates that endothelial cells speciﬁcally select VAMP 3 over VAMP8 to cooperate with syntaxin 4 and
SNAP23 in the Ca2+-triggered fusion of WPB with the plasma membrane. This article is part of a Special Issue
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The endothelium is a highly dynamic cell layer capable of
responding to environmental signals by presenting either an anti-
coagulant surface supporting unrestricted blood ﬂow (normal
condition) or a pro-thrombotic one that is capable of attracting
leukocytes and platelets (activated condition). Hence, endothelial
cells not only provide a physical barrier ensuring tightness of the
vessel system but can also be considered gatekeepers of vascular
homeostasis. They achieve this by sensing vascular perturbation
and secreting in a tightly controlled manner soluble factors and
membrane-associated proteins that regulate blood clotting, ﬁbrinolysis
and local inﬂammatory responses (for review see [1,2]). These factors
are stored in different types of endothelial granules that are capable of
undergoing stimulus-induced secretion. The most prominent of these
secretory granules are the Weibel–Palade bodies (WPBs), large, cigar-
shaped organelles that store the thrombogenic von Willebrand factor
(vWF) and the leukocyte receptor P-selectin [3]. WPBs are formedthrough a complex maturation process that is dictated by the
maturation of vWF. Following initial emergence at the trans-Golgi
network (TGN), WPBs acquire additional components from the
endosomal system as well as cytoplasmically associated proteins such
as the small GTPase Rab27a, thus sharing some characteristics with
lysosome-related organelles such as pigment-storing melanosomes.
Maturation of WPB is also accompanied by a movement of the
organelles from the perinuclear region to more peripheral locations
(for reviews see [4–6]).
To properly function in the control of thrombosis and the capture
of platelets and leukocytes, the WPB constituents have to be released
on demand. This is ensured by regulated exocytosis of WPB that can
be triggered by a rise in intracellular Ca2+ or cAMP levels (for reviews
see [7,8]). Typical secretagogues initiating the secretion of vWF are
histamine and thrombin that act by elevating intraendothelial Ca2+.
Despite the prominent role of WPB constituents in the initiation of
vascular thrombosis and leukocyte adherence comparatively little is
known about the molecular machinery driving their regulated
exocytosis. Several small GTPases have been implicated in the Ca2+-
evoked secretion of WPB. While Rab3D most likely functions in the
maturation of the organelle [9], Rab27a participates in a peripheral
storage of WPB acting as a negative regulator of secretion that
prevents premature release [10]. Serving positive regulatory func-
tions, RalA and its exchange factor RalGDS are required for efﬁcient
thrombin, i.e. Ca2+-dependent, as well as epinephrin, i.e. cAMP-
dependent, secretion of WPB [11–13]. Alpha-synuclein appears to
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Components of the cytoskeleton and cytoskeleton-regulating systems
have also been reported to participate in regulating the motility and/
or secretion of WPB, including the dynein–dynactin complex, the
microﬁlament system and its regulator RhoA [4,15,16]. Furthermore,
it has been shown that the formation of secretion-competent WPB
requires the adaptor protein-1 (AP1) and its effectors clathrin,
aftiphilin and gamma-synergin [17,18] and that protein phosphatase
2B appears to act as a negative regulator of WPB exocytosis since its
inhibition triggers vWF release [19].
While many of the factors listed above affect the maturation and
intracellular positioning/motility of WPB, little is known about the
endothelial components acting at the actual site of fusion between
WPB and the plasma membrane. This process appears to require
speciﬁc changes in the plasma membrane phospholipid composition,
speciﬁcally a phospholipase D1-mediated increase in phosphatidic
acid (PA), and the action of the annexin A2-S100A10 complex that is
capable of interacting with PA [9,20]. Finally, it has been shown that
N-ethylmaleimide-sensitive factor (NSF) and proteins of the soluble
NSF attachment protein receptor (SNARE) family participate in acute
vWF release since NO-mediated nitrosylation of NSF inhibits the
secretion of vWF [21]. Following up on these results we here set out to
identify the SNARE complex acting in the Ca2+-dependent exocytosis
of WPB in human endothelial cells. We show that two v-SNAREs,
VAMP3 and VAMP8, are present onWPB and that only VAMP3 forms a
trans-SNARE complex with syntaxin 4 (Syx4) and SNAP23 and
appears to be functionally required for WPB secretion.
2. Materials and methods
2.1. Antibodies and plasmids
WPBs were stained with mouse monoclonal (clone F8/86) and
rabbit polyclonal anti-human vWF-antibodies (Dako, Glostrup,
Denmark). A rabbit anti-human vWF peroxidase conjugate (Dako)
was applied for the quantiﬁcation of secreted vWF. Rabbit polyclonal
antibodies against human Syx4, SNAP23, VAMP3 and VAMP8 were
obtained from Synaptic Systems (Göttingen, Germany). Mouse
monoclonal anti-human Syx4 (clone 49) antibodies were from BD
(Franklin Lakes, NJ) and mouse monoclonal antibodies against human
vimentin from Dianova (Hamburg, Germany). Secondary anti-mouse
and anti-rabbit antibodies coupled to Texas Red, Cy2 or FITC were
purchased from Dianova and peroxidase conjugated secondary anti-
mouse and anti-rabbit antibodies were from Dako.
The coding sequences of human VAMP3 and VAMP8 were cloned
into pEGFP-N1 to generate plasmids encoding GFP-VAMP3 and GFP-
VAMP8. For bacterial expression, the cytoplasmic domains of human
VAMP3 (aa 1–78) and VAMP8 (aa 1–74) were subcloned into pGEX-
4T1 (GE Healthcare, Chalfont St. Giles, UK). The eukaryotic expression
vector encoding tetanus toxin light chain was kindly provided by
Thomas Binz (Hannover Medical School) [22].
2.2. Cell culture, transfection and RNAi
Primary cultures of human umbilical vein endothelial cells
(HUVECs) were established from umbilical cords and cultivated as
described [9,23]. Transfection of HUVECs was carried out as described
previously [9]. Nearly conﬂuent cells between passages 2 and 5 were
used in the experiments.
siRNA-mediated silencing of SNARE proteins employed RNA-
duplexes with dTdT 3′-overhang on both strands (Sigma-Aldrich, St.
Louis, MO). The Syx4 targeting siRNA has been described previously
[24]. RNAi-mediated silencing of VAMP3 and VAMP8 was carried out
in each case by transfection of equimolar amounts of two different
targeting oligos. The sequences used were as follows: SNAP23
(NM_003825.2, 367–385, 5′-CUUUGAGUCUGGCAAGGCU-3′),VAMP3 #1 (NM_004781.3, 2169–2189, 5′-CACUGUAAUCAC-
CUAAAUAAA-3′), VAMP3 #2 (NM_004781.3, 1462–1482, 5′-
CCCAAAUAUGAAGAUAAACUA-3′), VAMP8 #1 (NM_003761.3, 386–
404, 5 ′-CCUCUUCAUUGUGCUCUUU-3 ′) and VAMP8 #2
(NM_003761.3, 237–255, 5′-GAAAACUUGGAACAUCUCC-3′). Control
experiments used non-targeting control siRNAs (siGenome non-
targeting siRNA; Dharmacon, Chicago, IL). Cells were transfected with
200 pmol of targeting or control siRNA by nucleofection.
2.3. Cell lysate preparation
Cells were lysed in ice-cold lysis buffer (20 mM N-2-hydroxyethyl-
piperazine–N′-2-ethanesulfonic acid (HEPES), pH 7.4, 150 mM NaCl,
and 0.5% Triton X-100, with complete EDTA-free protease inhibitor
cocktail (Roche, Basel, Switzerland)) by passage through a 23 gauge
needle. Lysates were then cleared by centrifugation for 10 min at
1000 g. The corresponding supernatants were supplemented with
SDS (sodium dodecyl sulfate) sample buffer (50 mM Tris/HCl, pH 6.8,
2% SDS, 10% glycerol, 0.02% bromophenol blue, supplemented with
fresh 50 mM DTT), boiled for 5 min at 95 °C and subjected to analysis
by SDS-PAGE and immunoblotting.
2.4. Confocal microscopy
For analyzing the distribution of SNAREs by immunoﬂuorescence
(IF), cells were ﬁxed and permeabilized with 35% dimethyl sulfoxide
(DMSO)/methanol for 2 min at 4 °C. Blocking of samples was carried
out in 10% fetal calf serum (FCS) before incubation with primary and
the respective secondary antibodies, diluted in 2% bovine serum
albumin (BSA)/PBS. Mounted coverslips were imaged by confocal
microscopy (LSM510; Zeiss, Jena, Germany).
2.5. Immunoprecipitation
In order to stabilize SNARE complexes, cells were treated for
15 min with 1 mMN-ethylmaleimide (NEM) in ice-cold PBS to inhibit
NSF and thus prevent SNARE disassembly. Subsequently, cells were
washed, and further incubated in PBS supplemented with 2 mM DTT
for 15 min on ice. Cell extracts were prepared by scraping the 4 107
cells into lysis buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 0.2% NP-
40, 1 mM EDTA, 1 mM EGTA, 1 mM CaCl2, and 2 mM NEM, with
complete EDTA-free protease inhibitor cocktail) and subsequent
passage through a 23 gauge needle. The lysates were then cleared
by centrifugation for 10 min at 1000 g and 4 °C. For immunoprecip-
itation (IP), a 700 μg cell extract was mixed with prewashed anti-
mouse Dynabeads® (Invitrogen Dynal AS, Hamburg, Germany)
coupled with 3 μg of the mouse monoclonal anti-human syntaxin 4
antibodies and incubated for 2 h at 4 °C. Immunocomplexes were
washed ﬁve times with washing buffer (20 mM HEPES, pH 7.4,
300 mM NaCl, 0.2% NP-40, 0.1% Triton X-100, 1 mM EDTA, 1 mM
EGTA, and 1 mM CaCl2) and analyzed by SDS-PAGE and
immunoblotting.
2.6. Quantiﬁcation of vWF secretion
HUVECs grown to conﬂuency on collagen coated 24-well plates
were starved overnight in basal medium (1% BSA/M199; PAA,
Pasching, Austria). Regulated secretion was triggered by incubation
with 20 μM histamine (Sigma-Aldrich) in basal medium for 20 min at
37 °C. Control experiments used secretagogue-free basal medium to
measure the levels of constitutive secretion. Relative amounts of vWF
in the cell culture supernatants were then determined by ELISA as
described previously [20]. Potential differences in the releasable pool
of vWF were prevented by using the same batch of HUVECs for each
experiment and plating control and knockdown cells at similar
conﬂuencies. Results obtained with different batches of cells were
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stimulated secretion. Therefore, the constitutive secretion was set to
100%, and the values obtained with histamine-treated cells were then
expressed as difference between constitutive and regulated secretion.
2.7. Recombinant expression and puriﬁcation of dominant-negative
VAMP3 and VAMP8
Escherichia coli (strain BL21 (DE3) pLysS) cultures were trans-
formed with pGEX-4T1 constructs encoding GST or N-terminal GST-
tagged cytoplasmic domains of VAMP3 or VAMP8 and grown to an
A600 of 0.6. Recombinant protein expression was then induced by
addition of 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). After
3 h of cultivation, cells were harvested by centrifugation (5000 g for
10 min) and resuspended in lysis buffer (40 mM HEPES, pH 7.2,
300 mM NaCl, 10 mM β-mercaptoethanol, and 1.5 mM PMSF, with
complete protease inhibitor cocktail). After lysing the cells by triple
freeze/thaw cycles and sonication, the lysates were cleared by
centrifugation for 1 h at 100,000 g. The respective supernatants
were applied to a glutathione-Sepharose 4B (GE Healthcare) column
equilibrated in PBS. After extensive washing with the same buffer,
bound GST and GST-tagged VAMP3 and VAMP8 derivatives were
eluted with 20 mM glutathione (AppliChem, Darmstadt, Germany) in
50 mM Tris–HCl, pH 8.0.
2.8. Ca2+-evoked vWF secretion from streptolysin O-permeabilized
HUVECs
On 24-well plate grown conﬂuent HUVECs were starved overnight
in basal medium and permeabilized as described [25] with some
modiﬁcations. Cells were treated with 150 ng/ml streptolysin O (SLO)
in EGTA-supplemented permeabilization buffer (20 mM HEPES, pH
7.2, 120 mM KCl, 20 mM potassium acetate, 4 mM MgCl2, and 0.1%
BSA) for 5 min on ice. Subsequently, unbound SLO was removed by
washingwith PBSwithout Ca2+/Mg2+, and 1 mMEGTA. The efﬁciency
of the protocolwas veriﬁed by analyzing the uptake of trypan blue and
GST or GST-core SNARE fusion proteins into the permeabilized cells
(not shown). Following permeabilization cells were incubated for
10 min at 37 °C with 30 μM of the puriﬁed VAMP3 or VAMP8
derivatives (rebuffered in permeabilization buffer with 1 mM EGTA).
Regulated vWF secretion was induced by treating the permeabilized
HUVECs for 20 min at 37 °C with Ca2+-containing stimulation buffer
(permeabilization buffer supplemented with 10 μM CaCl2, 1 mM ATP,
3 mM creatine phosphate, and 1 μM creatine kinase). Control experi-
ments used permeabilized cells incubated for 20 min with EGTA-
containing permeabilization buffer to measure the levels of constitu-
tive secretion. The relative amounts of secreted vWF in the cell culture
supernatants were then quantiﬁed via the vWF-speciﬁc ELISA.
2.9. Statistical analysis
Graphs and associated statistics were generated with GraphPad
Prism version 4.00 for Windows software (GraphPad Software, San
Diego, CA) and values are given as mean±s.e.m.. Signiﬁcance of
differences was calculated with Student's unpaired t test; ns, not
signiﬁcant; *Pb0.05; **Pb0.005; ***Pb0.0005.
3. Results
3.1. A streptolysin O-permeabilized cell system to study endothelial cell
secretion
To verify the involvement of NSF in regulated secretion in human
umbilical vein endothelial cells (HUVECs) and to establish a
permeabilized cell system for this secretory event that would allow
the introduction of larger molecules into the cells, we made use of thebacterial toxin streptolysin O (SLO). SLO had been used previously to
generate permeabilized cells capable of mounting speciﬁc secretory
responses (for reviews see [26,27]). HUVECs were permeabilized by
activating membrane-bound SLO through warming up to 37 °C and
exocytosis of WPB, which remained intact during this treatment, was
triggered by incubating the SLO-treated cells in medium containing
elevated Ca2+ (Fig. 1A). This protocol led to the Ca2+-dependent
release of vWF into the cell supernatant indicative of exocytotic fusion
of WPB membranes with the plasma membrane (Fig. 1B). Next we
introduced N-ethylmaleimide (NEM) known to inhibit NSF function
into the permeabilized cells. Fig. 1B reveals that this treatment
basically abolished the Ca2+-triggered release of vWF from the
permeabilized cells. Thus, at least in this minimal system WPB
exocytosis is sensitive to NEM inhibition indicative of the involvement
of NSF as observed previously in aortic endothelial cells [21].
3.2. WPB-associated SNARE proteins
Given an established function of NSF in Ca2+-triggered WPB
exocytosis (Fig. 1B and [21]) we next searched for endothelial SNARE
proteins that could be involved in vWF secretion and thereby function
as targets of NSF in the course of these events. We followed a
candidate approach and probed immunoblots of HUVEC lysates with a
panel of SNARE-speciﬁc antibodies. Fig. 2A shows that the t-SNAREs
syntaxin 4 (Syx4) and SNAP23 as well as the v-SNAREs VAMP3 and
VAMP8 are expressed in HUVECs. This differs to some extent from a
previous report that revealed the presence of Syx4, SNAP23 and
VAMP3 but failed to detect VAMP8 in endothelial cells from aortic
origin [21]. We also carried out an immunoﬂuorescence analysis that
corroborated the plasma membrane localization of Syx4 and SNAP23.
Interestingly, this analysis also showed that the two v-SNAREs
identiﬁed in HUVECs, VAMP3 and VAMP8, are both predominantly
found on WPB (Fig. 2B–D). The speciﬁcity of this observation was
conﬁrmed by recording the distribution of GFP-tagged VAMP3 and
VAMP8 in live HUVECs, which again revealed their WPB association
(not shown).
Given the speciﬁc WPB localization of VAMP3 and VAMP8 we next
determined whether these proteins can engage in trans-SNARE
complex formation with plasma membrane-resident Syx4 and/or
SNAP23. Such complexes could represent substrates for the action of
NSF and thus elements of the machinery mediating WPB exocytosis.
Following NEM treatment to prevent NSF-mediated SNARE disassem-
bly HUVECs were lysed and the lysates subjected to anti-Syx4
immunoprecipitation. Western blot analysis revealed the co-immu-
noprecipitation of SNAP23 and VAMP3 but not VAMP8 (Fig. 3). Thus,
WPB-associated VAMP3, but not VAMP8, can engage in complexes
with plasma membrane-resident Syx4 and SNAP23 identifying this
SNARE complex as a possible intermediate in WPB exocytosis.
3.3. Involvement of WPB-associated SNAREs in Ca2+-triggered vWF
secretion
To provide evidence for a functional involvement in Ca2+-
dependent WPB exocytosis we next attempted to downregulate the
SNAREs identiﬁed above by RNAi approaches. Efﬁcient knockdown
could be achieved by transfection of primary HUVECs with speciﬁc
siRNA duplexes (Fig. 4A shows an example for SNAP23). HUVEC
populations depleted of the individual SNAREs were then subjected to
histamine stimulation and the amount of vWF acutely released was
measured as compared to mock transfected control cells. None of the
depletions had a signiﬁcant effect on the histamine-induced secretion
of WPB-resident vWF. One example is shown for SNAP23 in Fig. 4B.
Although a slight decrease in the regulated vWF release was seen, the
effects observed never proved to be statistically signiﬁcant. Such lack
of signiﬁcant functional consequences of SNARE knockdown is not
without precedence (see, for example, [28–30], and a detailed analysis
Fig. 1. Inhibition of the ATPase NSF reduces Ca2+-evoked vWF secretion in HUVECs. (A) Schematic representation of the SLO-permeabilized cell system. HUVECs are permeabilized
with SLO and subsequently incubated with potentially inhibitory molecules in the absence of calcium. The regulated vWF secretion is then induced by the application of 10 μmCaCl2.
(B) Selective NSF inhibition by NEM treatment interferes with the Ca2+-triggered vWF secretion. After treating the SLO-permeabilized HUVECs with 2 mM NEM the cells were
subjected to incubation with Ca2+-containing stimulation buffer for 20 min. Control experiments used permeabilized cells incubated for 20 min with EGTA-containing
permeabilization buffer to measure the levels of constitutive secretion. The acute release of vWF into the cell culture supernatant was then quantiﬁed by a vWF-speciﬁc ELISA. The
relative Ca2+-triggered increase of vWF secretion exceeding the constitutive level is given in percentage as the mean value±s.e.m.. The effect on secretion was quantiﬁed in sets of
independent experiments (number of experiments shown at the base of the graph). Student's unpaired t test was performed to evaluate statistical signiﬁcance (*Pb0.05).
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the system allowing for functional compensation and the capability of
low levels of SNARE proteins in maintaining proper organelle fusion.
To corroborate this for endothelial cells, i.e. to show that lower levels
of the SNARE complex identiﬁed above can mediate efﬁcient WPB
exocytosis, we also applied a different approach for SNARE down-
regulation and ectopically expressed the proteolytically active tetanus
toxin light chain (TeNT LC) in HUVECs. TeNT LC is known to cleave
VAMP3 (for review see [32]) and thus is capable of reducing the
amount of active VAMP3 also in complexes that are potentially not
sensitive to high turnover and thus the siRNA approach. Fig. 4C reveals
that TeNT expressing HUVECs show amarkedly reduced level of intactFig. 2. Expression and subcellular localization of selected SNARE proteins in HUVECs. (A) Imm
Total lysates from rat brain tissue and HUVECs were analyzed by Western blot using pol
standards are indicated on the left (kDa). (B) Immunoﬂuorescence staining of the endogenou
(D). The subcellular localization of the two VAMPs is shown in comparison to that of vWF. Box
10 μm.VAMP3. However, despite this reduction histamine-stimulated vWF
secretion is not affected indicating that the residual VAMP3 present is
sufﬁcient to support WPB exocytosis (Fig. 4D).
To overcome the potential problem of the siRNA approaches, i.e.
the presence of residual SNARE protein levels sufﬁcient to support
WPB exocytosis, we employed the SLO system, which faithfully
reproduced Ca2+-triggered WPB exocytosis (see Fig. 1), to introduce
high levels of SNARE mutant proteins that could act in a dominant-
negative fashion. We chose mutants covering the cytosolic SNARE
domains that engage in trans-SNARE coiled–coil interactions in the
course of granule–plasma membrane fusion. Such cytosolic domains
have been employed previously as dominant-negative toolsunoblot revealing expression of Syx4, SNAP23, VAMP3 and VAMP8 proteins in HUVECs.
yclonal anti-human Syx4, SNAP23, VAMP3 and VAMP8 antibodies. Molecular weight
s t-SNAREs Syx4 and SNAP23 and of the endogenous v-SNAREs VAMP3 (C) and VAMP8
ed images represent enlarged parts of the corresponding stainings. Scale bars represent
Fig. 3. Syntaxin 4, SNAP23 and VAMP3 form a complex in HUVECs. NEM-treated HUVEC
lysates were subjected to immunoprecipitation usingmouse anti-Syx4 or non-targeting
isotype speciﬁc IgGs (control). Aliquots of the starting material (total lysate), the
supernatant after immunoprecipitation and the immunocomplexes (IP) were probed
by Western blot with polyclonal anti-Syx4, -SNAP23, -VAMP3 and -VAMP8 antibodies.
Two parallel immunoprecipitations using the same total lysate were probed by
Western blotting to determine the precipitation of either VAMP3 or VAMP8. Molecular
weight standards are indicated on the left (kDa).
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SNARE complexes, thereby inhibiting SNARE function in the course of
membrane fusion events (see, for example, [33–35]). To focus onWPB
exocytosis we concentrated on the two WPB-associated SNAREs
identiﬁed above, VAMP3 and VAMP8. GST-tagged versions of the
cytosolic VAMP3 and VAMP8 domains were expressed in bacteria,
puriﬁed and introduced into SLO-permeabilized HUVECs. GST aloneFig. 4. Histamine-evoked vWF secretion is not affected signiﬁcantly by siRNA-mediated SN
transiently transfected with 200 pmol of siRNA speciﬁc to SNAP23 or non-targeting contro
Western blot using rabbit polyclonal anti-SNAP23 antibodies to reveal the knockdown efﬁ
Molecular weight standards are indicated on the left (kDa). (B) Quantiﬁcation of vWF secre
after transfection with targeting siRNA or siControl, HUVECs were subjected to histamine
treating the cells with secretagogue-free basal medium. The acute release of vWF into th
histamine-triggered increase of vWF secretion exceeding the constitutive level is given in p
independent experiments (number of experiments shown at the base of the graph). Student
(C) Analysis of selective VAMP3 degradation by tetanus toxin. HUVECs were transiently tran
transfection was included. 24 h after transfection the efﬁciency of VAMP3 degradation was m
using rabbit polyclonal anti-VAMP3 antibodies. Probing with a monoclonal anti-vimentin an
left (kDa). (D) Quantiﬁcation of vWF secretion from histamine-stimulated HUVECs depleted
transfection, histamine-triggered vWF secretion was quantiﬁed as described for SNAP23 deserved as a negative control. WPB exocytosis was then induced by
elevating the Ca2+ concentration and vWF release in response to the
Ca2+ trigger was recorded by immunodetection of the protein in the
cell supernatant. Fig. 5 reveals that cells loaded with the cytosolic
mutant of VAMP3 showed a signiﬁcantly reduced vWF secretion. In
contrast, no inhibitory effect was observed when GST alone (not
shown) or the cytosolic VAMP8 mutant were employed. Thus, in
line with the co-immunoprecipitation experiments (Fig. 3) WPB-
associated VAMP3, but not VAMP8, appears to be primarily involved
in mediating Ca2+-induced WPB exocytosis, most likely in conjunc-
tion with Syx4 and SNAP23.
4. Discussion
Acute secretion of granule contents enables endothelial cells to
respond in a dynamic and tightly regulated manner to an altered
vascular milieu. Factors released from endothelial cells by such means
include the thrombogenic and inﬂammatory platelet and leukocyte
receptors vWF and P-selectin as well as the ﬁbrinolytic tPA. Several
lines of evidence suggest that the morphology of the respective
storage granules for vWF/P-selectin and tPA, respectively, and the
mechanisms, regulation and molecular machineries underlying their
exocytotic release differ from one another [9,20,36,37]. Such differ-
ences could equip endothelial cells withmeans to selectively drive the
secretion of either thrombogenic or ﬁbrinolytic granule contents in
response to certain stimuli. Thus, understanding molecular details of
the different release pathways is required to eventually control the
thrombogenic or ﬁbrinolytic responses of endothelial cells in a highly
speciﬁc manner.AP23 downregulation. (A) Analysis of the efﬁciency of SNARE depletion. HUVECs were
l siRNA (siControl). 48 h after transfection, cell lysates were prepared and analyzed by
ciency. Probing with a polyclonal anti-Syx4 antibody was included as loading control.
tion from histamine-stimulated HUVECs depleted of SNAP23 by siRNA treatment. 48 h
treatment for 20 min. In parallel levels of constitutive secretion were determined by
e cell culture supernatant was then quantiﬁed by a vWF-speciﬁc ELISA. The relative
ercentage as the mean value±s.e.m.. The effect on secretion was quantiﬁed in sets of
's unpaired t test was performed to evaluate statistical signiﬁcance (ns, not signiﬁcant).
sfected with a construct encoding tetanus toxin light chain. As negative control a mock
onitored by preparation of cell lysates and subsequent Western blotting of these lysates
tibody was included as loading control. Molecular weight standards are indicated on the
of the majority of intact VAMP3 by tetanus toxin treatment. 24 h after TeNT LC or mock
pletion.
Fig. 5. Dominant-negative VAMP3 affects Ca2+-evoked vWF secretion from SLO-
permeabilized HUVECs. Quantiﬁcation of the Ca2+-evoked vWF secretion of SLO-
permeabilized HUVECs treated with dominant-negative VAMP8 or VAMP3. After
treating the SLO-permeabilized HUVECs with 30 μM GST, or the GST-tagged
cytoplasmic domains of VAMP8 or VAMP3 the cells were subjected to incubation
with Ca2+-containing stimulation buffer for 20 min. Control experiments used
permeabilized cells incubated for 20 min with EGTA-containing permeabilization
buffer to measure the levels of constitutive secretion. The acute release of vWF into the
cell culture supernatant was then quantiﬁed by a vWF-speciﬁc ELISA and values for the
relative Ca2+-triggered increase of vWF secretion (calculated as difference to the
constitutive level which was set to 100%) were evaluated statistically by Student's
unpaired t test (ns, not signiﬁcant; *Pb0.05). The graph shows the relative inhibition of
Ca2+-evoked vWF secretion in comparison to cells treated with GST alone in percentage
as themean value±s.e.m.. The effect on secretion was quantiﬁed in sets of independent
experiments (number of experiments shown at the base of each column).
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endothelial cells we show here that two SNARE proteins, VAMP3 and
VAMP8, are present on WPBs, the storage granules of vWF and P-
selectin. Of those two, only VAMP3 forms a complex with two plasma
membrane-resident SNAREs of endothelial cells, Syx4 and SNAP23,
and inhibition experiments in SLO-permeabilized endothelial cells
suggest that only VAMP3 contributes to the Ca2+-regulated secretion
of vWF. Although considered to primarily function in endosomal
recycling, VAMP3 has also been shown to associate with and
participate in the release of different types of secretory granules (for
review see [32]). Most relevant to vascular haemostasis is probably
the presence of VAMP3 on alpha-granules of platelets that also serve
as storage organelles for both, vWF and P-selectin. VAMP8 was also
found on platelet alpha-granules and targeting of VAMP3 and VAMP8
by introducing soluble protein mutants into SLO-permeabilized
platelets had revealed that only VAMP3 appeared to be required for
alpha-granule exocytosis [38]. Thus, in addition to their cargo, alpha-
granules andWPB share two R-SNAREs that speciﬁcally associate with
these organelles suggesting that common recruitment mechanisms
are operating in platelets and endothelial cells. These results also
suggest that VAMP3, but not VAMP8, is an important SNARE
mediating the exocytosis of alpha-granules and WPB, respectively.
WPBs of HUVECs contain at least two v-SNAREs, VAMP3 and
VAMP8, whereas aortic endothelial cells only appear to express
VAMP3 [39]. Since VAMP8 has also been shown to engage in complex
formation with Syx4 and SNAP23 (see, for example, [40]), endothelial
cells have established a mechanism that selects one WPB-associated
v-SNARE (VAMP3) over the other (VAMP8) for plasma membrane t-
SNARE engagement and exocytotic membrane fusion. Furthermore,
our ﬁndings raise the question about the function of WPB-associated
VAMP8 since it is not involved in Ca2+-regulated secretion. Given the
complex biogenesis of WPB it is possible that VAMP8 functions in
membrane fusion events occurring during WPB maturation. Future
studies have to address this question.
Complexes of VAMP3, Syx4 and SNAP23 can be co-immunopre-
cipitated from endothelial cells indicating that VAMP3 forms a trans-
SNARE complex with Syx4 and SNAP23 to support WPB exocytosis.
This is in line with experiments in permeabilized aortic endothelial
cells that showed an inhibitory effect of Syx4 antibodies on vWF
secretion [21]. Future studies have to reveal other components of the
SNARE machinery, e.g. associated Munc18, Munc13 or synaptotagmin
isoforms that participate in the Ca2+-dependent release of WPB.Furthermore, it has ultimately to be established whether the same or
different protein networks function in tPA granule exocytosis.Acknowledgements
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